To include your compound in the COVID-19 Resource Center, submit it here.
Ears, nose and throat disease company Lyra Therapeutics Inc. (Watertown, Mass.) raised $29.5 million in a series B round led
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury